Can hTERT peptide540-548-specific CD8 T cells recognize and kill tumor cells?

Cancer immunity

Daniel E. Speiser²  Pedro Romero²  , Jean-Charles Cerottini¹ 

[1] Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandLudwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, SwitzerlandDivision of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandDivision of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandLudwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, SwitzerlandLudwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, SwitzerlandDivision of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandLudwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland;Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandDivision of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandDivision of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

关键词: human;    cytotoxic T lymphocytes;    HLA-A2;    telomerase;    peptide;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown